Peter Frederick Curwen

Title: Innovations by Peter Frederick Curwen

Introduction

Peter Frederick Curwen is an accomplished inventor based in Kensington, Australia. He has made significant contributions to the field of neuroscience, particularly in the treatment of neurological conditions. With a total of 2 patents to his name, Curwen's work is recognized for its innovative approaches to complex medical challenges.

Latest Patents

Curwen's latest patents focus on the treatment of inflammatory neurodegenerative conditions of the central nervous system (CNS). The first patent describes a method for treating such conditions by administering a G-CSF or G-CSFR inhibiting agent. This agent can be an antibody specific for G-CSF or G-CSFR, a soluble G-CSFR, or a G-CSF-binding portion thereof. Additionally, it includes a 20 to 30 nucleotide sense or antisense molecule targeted to a nucleic acid molecule encoding G-CSF. This innovative approach aims to provide new therapeutic options for patients suffering from these debilitating conditions.

Career Highlights

Curwen is currently associated with CSL Limited, a leading global biotechnology company. His work at CSL Limited has allowed him to further develop his research and contribute to advancements in medical treatments. His dedication to innovation in the field of neuroscience has positioned him as a notable figure among his peers.

Collaborations

Curwen has collaborated with esteemed colleagues such as Brent Steven McKenzie and Eugene Maraskovsky. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the treatment of neurological disorders.

Conclusion

Peter Frederick Curwen's contributions to the field of neuroscience through his patents and collaborations highlight his commitment to advancing medical science. His innovative methods for treating neurological conditions demonstrate the potential for significant improvements in patient care.